BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24807047)

  • 1. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
    Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Oshima T; Yanagihara K; Oue N; Yasui W
    Pathobiology; 2014; 81(3):138-48. PubMed ID: 24642718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
    Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
    Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers.
    Takei Y; Shen G; Morita-Kondo A; Hara T; Mihara K; Yanagihara K
    Pathobiology; 2018; 85(4):232-246. PubMed ID: 29847827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
    Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion.
    Yagi R; Tanaka M; Sasaki K; Kamata R; Nakanishi Y; Kanai Y; Sakai R
    Oncogene; 2011 Mar; 30(12):1413-21. PubMed ID: 21076469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma.
    Tanaka M; Kamata R; Takigahira M; Yanagihara K; Sakai R
    Am J Pathol; 2007 Jul; 171(1):68-78. PubMed ID: 17591954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
    Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
    Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms responsible for the progression of scirrhous gastric cancer].
    Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K
    Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA HOTAIR Promotes Epithelial-Mesenchymal Transition and Is a Suitable Target to Inhibit Peritoneal Dissemination in Human Scirrhous Gastric Cancers.
    Takei Y; Hara T; Suzuki A; Mihara K; Yanagihara K
    Pathobiology; 2020; 87(5):277-290. PubMed ID: 32937635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
    Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
    Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and progression of scirrhous carcinoma].
    Naito Y; Kino I
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.
    Uekita T; Tanaka M; Takigahira M; Miyazawa Y; Nakanishi Y; Kanai Y; Yanagihara K; Sakai R
    Am J Pathol; 2008 Jun; 172(6):1729-39. PubMed ID: 18467693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
    Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
    Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of p53 and vascular endothelial growth factor expression of clinicopathological factors in human scirrhous gastric cancer.
    Baba M; Konno H; Maruo Y; Tanaka T; Kanai T; Matsumoto K; Matsuura M; Nishino N; Maruyama K; Nakamura S; Baba S
    Eur Surg Res; 1998; 30(2):130-7. PubMed ID: 9565747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of Livin in gastric cancer.
    Chung CY; Park YL; Kim N; Park HC; Park HB; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Oncol Rep; 2013 Nov; 30(5):2520-8. PubMed ID: 24008725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.